nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—GABRA3—Graves' disease	0.617	1	CbGaD
Bromazepam—CYP2E1—Methimazole—Graves' disease	0.113	0.399	CbGbCtD
Bromazepam—CYP2C19—Methimazole—Graves' disease	0.0707	0.25	CbGbCtD
Bromazepam—CYP1A2—Methimazole—Graves' disease	0.0653	0.231	CbGbCtD
Bromazepam—CYP3A4—Methimazole—Graves' disease	0.0342	0.121	CbGbCtD
Bromazepam—GABRQ—GABA A receptor activation—GABRA3—Graves' disease	0.00366	0.041	CbGpPWpGaD
Bromazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00301	0.0337	CbGpPWpGaD
Bromazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00297	0.0332	CbGpPWpGaD
Bromazepam—GABRA6—GABA A receptor activation—GABRA3—Graves' disease	0.00281	0.0315	CbGpPWpGaD
Bromazepam—GABRA4—GABA A receptor activation—GABRA3—Graves' disease	0.00277	0.0311	CbGpPWpGaD
Bromazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00254	0.0284	CbGpPWpGaD
Bromazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00246	0.0276	CbGpPWpGaD
Bromazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00238	0.0266	CbGpPWpGaD
Bromazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00236	0.0265	CbGpPWpGaD
Bromazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00235	0.0263	CbGpPWpGaD
Bromazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00232	0.026	CbGpPWpGaD
Bromazepam—GABRQ—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00224	0.0251	CbGpPWpGaD
Bromazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00224	0.0251	CbGpPWpGaD
Bromazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00203	0.0227	CbGpPWpGaD
Bromazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00184	0.0207	CbGpPWpGaD
Bromazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00182	0.0204	CbGpPWpGaD
Bromazepam—GABRA6—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00172	0.0193	CbGpPWpGaD
Bromazepam—GABRA4—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0017	0.019	CbGpPWpGaD
Bromazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00155	0.0174	CbGpPWpGaD
Bromazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00151	0.0169	CbGpPWpGaD
Bromazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00146	0.0163	CbGpPWpGaD
Bromazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00145	0.0162	CbGpPWpGaD
Bromazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00142	0.0159	CbGpPWpGaD
Bromazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00125	0.014	CbGpPWpGaD
Bromazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00124	0.0139	CbGpPWpGaD
Bromazepam—GABRQ—GABA receptor activation—GABRA3—Graves' disease	0.00119	0.0133	CbGpPWpGaD
Bromazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00119	0.0133	CbGpPWpGaD
Bromazepam—Clonazepam—GABRA3—Graves' disease	0.0011	0.22	CrCbGaD
Bromazepam—Clorazepate—GABRA3—Graves' disease	0.00107	0.213	CrCbGaD
Bromazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.000979	0.011	CbGpPWpGaD
Bromazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.000964	0.0108	CbGpPWpGaD
Bromazepam—GABRA6—GABA receptor activation—GABRA3—Graves' disease	0.000912	0.0102	CbGpPWpGaD
Bromazepam—GABRA4—GABA receptor activation—GABRA3—Graves' disease	0.000901	0.0101	CbGpPWpGaD
Bromazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000824	0.00923	CbGpPWpGaD
Bromazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.0008	0.00896	CbGpPWpGaD
Bromazepam—Nitrazepam—GABRA3—Graves' disease	0.000799	0.16	CrCbGaD
Bromazepam—Fludiazepam—GABRA3—Graves' disease	0.00078	0.156	CrCbGaD
Bromazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.000772	0.00865	CbGpPWpGaD
Bromazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.000767	0.00859	CbGpPWpGaD
Bromazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000753	0.00844	CbGpPWpGaD
Bromazepam—GABRQ—Orphan transporters—GABRA3—Graves' disease	0.000693	0.00776	CbGpPWpGaD
Bromazepam—Oxazepam—GABRA3—Graves' disease	0.000688	0.138	CrCbGaD
Bromazepam—GABRR3—eye—Graves' disease	0.000687	0.117	CbGeAlD
Bromazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000659	0.00738	CbGpPWpGaD
Bromazepam—GABRR2—eye—Graves' disease	0.000596	0.102	CbGeAlD
Bromazepam—GABRR1—eye—Graves' disease	0.000573	0.098	CbGeAlD
Bromazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000573	0.00642	CbGpPWpGaD
Bromazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000571	0.00639	CbGpPWpGaD
Bromazepam—Diazepam—GABRA3—Graves' disease	0.000564	0.113	CrCbGaD
Bromazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000562	0.0063	CbGpPWpGaD
Bromazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000546	0.00612	CbGpPWpGaD
Bromazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000546	0.00612	CbGpPWpGaD
Bromazepam—GABRA6—Orphan transporters—GABRA3—Graves' disease	0.000532	0.00596	CbGpPWpGaD
Bromazepam—GABRA4—Orphan transporters—GABRA3—Graves' disease	0.000525	0.00588	CbGpPWpGaD
Bromazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.00051	0.00571	CbGpPWpGaD
Bromazepam—GABRQ—Ion channel transport—GABRA3—Graves' disease	0.000486	0.00545	CbGpPWpGaD
Bromazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000486	0.00545	CbGpPWpGaD
Bromazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.00048	0.00538	CbGpPWpGaD
Bromazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000467	0.00523	CbGpPWpGaD
Bromazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.00045	0.00504	CbGpPWpGaD
Bromazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00045	0.00504	CbGpPWpGaD
Bromazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000447	0.00501	CbGpPWpGaD
Bromazepam—GABRG3—pituitary gland—Graves' disease	0.000447	0.0763	CbGeAlD
Bromazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000443	0.00496	CbGpPWpGaD
Bromazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000439	0.00492	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000431	0.00482	CbGpPWpGaD
Bromazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000419	0.0047	CbGpPWpGaD
Bromazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000414	0.00464	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000411	0.0046	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000411	0.0046	CbGpPWpGaD
Bromazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.0004	0.00448	CbGpPWpGaD
Bromazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000394	0.00442	CbGpPWpGaD
Bromazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000384	0.0043	CbGpPWpGaD
Bromazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000379	0.00424	CbGpPWpGaD
Bromazepam—GABRA6—Ion channel transport—GABRA3—Graves' disease	0.000373	0.00418	CbGpPWpGaD
Bromazepam—GABRA4—Ion channel transport—GABRA3—Graves' disease	0.000368	0.00413	CbGpPWpGaD
Bromazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000368	0.00412	CbGpPWpGaD
Bromazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000355	0.00398	CbGpPWpGaD
Bromazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000353	0.00395	CbGpPWpGaD
Bromazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000346	0.00388	CbGpPWpGaD
Bromazepam—GABRB1—pituitary gland—Graves' disease	0.000345	0.059	CbGeAlD
Bromazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000338	0.00379	CbGpPWpGaD
Bromazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000337	0.00377	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000333	0.00373	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.00033	0.0037	CbGpPWpGaD
Bromazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000327	0.00367	CbGpPWpGaD
Bromazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000316	0.00354	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000315	0.00353	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000315	0.00353	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—GABRA3—Graves' disease	0.000315	0.00353	CbGpPWpGaD
Bromazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000314	0.00352	CbGpPWpGaD
Bromazepam—GABRA4—pituitary gland—Graves' disease	0.000312	0.0532	CbGeAlD
Bromazepam—GABRA4—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000311	0.00349	CbGpPWpGaD
Bromazepam—GABRP—pituitary gland—Graves' disease	0.000309	0.0529	CbGeAlD
Bromazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000308	0.00345	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000303	0.00339	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000285	0.00319	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000277	0.0031	CbGpPWpGaD
Bromazepam—GABRA3—thyroid gland—Graves' disease	0.000276	0.0471	CbGeAlD
Bromazepam—GABRB3—eye—Graves' disease	0.00027	0.0461	CbGeAlD
Bromazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000269	0.00302	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000267	0.00299	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000265	0.00297	CbGpPWpGaD
Bromazepam—GABRG2—pituitary gland—Graves' disease	0.000261	0.0445	CbGeAlD
Bromazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00026	0.00292	CbGpPWpGaD
Bromazepam—GABRB3—connective tissue—Graves' disease	0.00026	0.0444	CbGeAlD
Bromazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.000259	0.0029	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000255	0.00286	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—GABRA3—Graves' disease	0.000242	0.00271	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—GABRA3—Graves' disease	0.000239	0.00267	CbGpPWpGaD
Bromazepam—GABRA2—adipose tissue—Graves' disease	0.000237	0.0405	CbGeAlD
Bromazepam—GABRE—pituitary gland—Graves' disease	0.000236	0.0404	CbGeAlD
Bromazepam—GABRE—adipose tissue—Graves' disease	0.000235	0.0402	CbGeAlD
Bromazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000228	0.00255	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000218	0.00244	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000212	0.00237	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000205	0.00229	CbGpPWpGaD
Bromazepam—GABRE—thyroid gland—Graves' disease	0.000204	0.0348	CbGeAlD
Bromazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000203	0.00228	CbGpPWpGaD
Bromazepam—GABRB3—pituitary gland—Graves' disease	0.0002	0.0342	CbGeAlD
Bromazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.0002	0.00223	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000177	0.00199	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000174	0.00195	CbGpPWpGaD
Bromazepam—GABRB3—thyroid gland—Graves' disease	0.000173	0.0295	CbGeAlD
Bromazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000169	0.0019	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000169	0.0019	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000139	0.00156	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000137	0.00154	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00013	0.00145	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000128	0.00144	CbGpPWpGaD
Bromazepam—CYP1A2—thyroid gland—Graves' disease	0.000122	0.0209	CbGeAlD
Bromazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000117	0.00131	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000114	0.00128	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00011	0.00123	CbGpPWpGaD
Bromazepam—CYP2E1—thyroid gland—Graves' disease	0.00011	0.0188	CbGeAlD
Bromazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000109	0.00122	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000107	0.0012	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	9.38e-05	0.00105	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Graves' disease	6.5e-05	0.000728	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Graves' disease	5.8e-05	0.000649	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	5.45e-05	0.000611	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—GC—Graves' disease	5.45e-05	0.000611	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.25e-05	0.000476	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	4.21e-05	0.000471	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	4.21e-05	0.000471	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	3.96e-05	0.000443	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—GC—Graves' disease	3.15e-05	0.000352	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—GC—Graves' disease	2.43e-05	0.000272	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—B3GNT2—Graves' disease	2.38e-05	0.000267	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—GC—Graves' disease	1.89e-05	0.000212	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—B3GNT2—Graves' disease	1.84e-05	0.000206	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—GC—Graves' disease	1.46e-05	0.000164	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—B3GNT2—Graves' disease	1.43e-05	0.000161	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.11e-05	0.000124	CbGpPWpGaD
